EIF2S2 and myeloproliferative disorder: These two proteins play a major role in one of the significantly disturbed pathways, i.e., EIF2 signalling and thus eukaryotic translation initiation, which is one of the significantly downregulated pathways that was identified between the MPN-DLBCL and R-DLBCL tumors.